These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 25204258)

  • 1. Pharmacoepidemiological study of drug-drug interactions in onco-hematological pediatric patients.
    Fernández de Palencia Espinosa MA; Díaz Carrasco MS; Fuster Soler JL; Ruíz Merino G; De la Rubia Nieto MA; Espuny Miró A
    Int J Clin Pharm; 2014 Dec; 36(6):1160-9. PubMed ID: 25204258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential drug-drug interactions in oncological adult inpatients at a Spanish hospital: epidemiology and risk factors.
    Fernández de Palencia Espinosa MÁ; Díaz Carrasco MS; Alonso Romero JL; de la Rubia Nieto A; Espuny Miró A
    Int J Clin Pharm; 2015 Dec; 37(6):1021-7. PubMed ID: 26391788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential drug-drug interactions in hospitalised haematological patients.
    Fernández de Palencia Espinosa MÁ; Díaz Carrasco MS; Sánchez Salinas A; de la Rubia Nieto A; Miró AE
    J Oncol Pharm Pract; 2017 Sep; 23(6):443-453. PubMed ID: 27511216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-drug interactions in pediatric oncology patients.
    Balk TE; van der Sijs IH; van Gelder T; Janssen JJB; van der Sluis IM; van Leeuwen RWF; Engels FK
    Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28205376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real clinical impact of drug-drug interactions of immunosuppressants in transplant patients.
    Gago-Sánchez AI; Font P; Cárdenas M; Aumente MD; Del Prado JR; Calleja MÁ
    Pharmacol Res Perspect; 2021 Dec; 9(6):e00892. PubMed ID: 34755493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of two databases to detect potential drug-drug interactions between prescriptions of HIV/AIDS patients in critical care.
    Ramos GV; Guaraldo L; Japiassú AM; Bozza FA
    J Clin Pharm Ther; 2015 Feb; 40(1):63-7. PubMed ID: 25329640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of adverse drug reactions in geriatric inpatients using a computerised drug database.
    Egger T; Dormann H; Ahne G; Runge U; Neubert A; Criegee-Rieck M; Gassmann KG; Brune K
    Drugs Aging; 2003; 20(10):769-76. PubMed ID: 12875612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospital admissions/visits associated with drug-drug interactions: a systematic review and meta-analysis.
    Dechanont S; Maphanta S; Butthum B; Kongkaew C
    Pharmacoepidemiol Drug Saf; 2014 May; 23(5):489-97. PubMed ID: 24616171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical relevance of drug-drug interactions in hospitalized dermatology patients.
    Ganeva M; Gancheva T; Troeva J; Kiriyak N; Hristakieva E
    Adv Clin Exp Med; 2013; 22(4):555-63. PubMed ID: 23986216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying adverse drug reactions associated with drug-drug interactions: data mining of a spontaneous reporting database in Italy.
    Leone R; Magro L; Moretti U; Cutroneo P; Moschini M; Motola D; Tuccori M; Conforti A
    Drug Saf; 2010 Aug; 33(8):667-75. PubMed ID: 20635825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 6-year retrospective study of adverse drug reactions due to drug-drug interactions between nervous system drugs.
    Shi QP; He XD; Yu ML; Zhu JX; Liu Y; Ding F; Sang R; Jiang XD; Zhang SQ
    Int J Clin Pharmacol Ther; 2014 May; 52(5):392-401. PubMed ID: 24691061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and analysis of drug-drug interactions among hospitalized cardiac patients in the Mohammed V Military Teaching Hospital in Morocco.
    Fettah H; Moutaouakkil Y; Sefrioui MR; Moukafih B; Bousliman Y; Bennana A; Lamsaouri J; Makram S; Cherrah Y
    Pan Afr Med J; 2018; 29():225. PubMed ID: 30100979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency, characteristics and risk factors of QT interval prolonging drugs and drug-drug interactions in cancer patients: a multicenter study.
    Khan Q; Ismail M; Khan S
    BMC Pharmacol Toxicol; 2017 Dec; 18(1):75. PubMed ID: 29191244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of clinically manifested drug interactions in hospitalized patients: A systematic review and meta-analysis.
    Gonzaga de Andrade Santos TN; Mendonça da Cruz Macieira G; Cardoso Sodré Alves BM; Onozato T; Cunha Cardoso G; Ferreira Nascimento MT; Saquete Martins-Filho PR; Pereira de Lyra D; Oliveira Filho AD
    PLoS One; 2020; 15(7):e0235353. PubMed ID: 32609783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying high risk medications causing potential drug-drug interactions in outpatients: A prescription database study based on an online surveillance system.
    Toivo TM; Mikkola JA; Laine K; Airaksinen M
    Res Social Adm Pharm; 2016; 12(4):559-68. PubMed ID: 26459026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of potential drug-drug interactions with metabolic syndrome medications detected by two databases.
    Suriyapakorn B; Chairat P; Boonyoprakarn S; Rojanarattanangkul P; Pisetcheep W; Hunsakunachai N; Vivithanaporn P; Wongwiwatthananukit S; Khemawoot P
    PLoS One; 2019; 14(11):e0225239. PubMed ID: 31725785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polypharmacy, aging and potential drug-drug interactions in outpatients in Taiwan: a retrospective computerized screening study.
    Lin CF; Wang CY; Bai CH
    Drugs Aging; 2011 Mar; 28(3):219-25. PubMed ID: 21250763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence, severity, and nature of risk factors associated with drug-drug interactions in geriatric patients receiving cancer chemotherapy: A prospective study in a tertiary care teaching hospital.
    Ramasubbu SK; Mahato SK; Agnihotri A; Pasricha RK; Nath UK; Das B
    Cancer Treat Res Commun; 2021; 26():100277. PubMed ID: 33348276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of potential drug-drug interactions in bone marrow transplant patients.
    Guastaldi RB; Reis AM; Figueras A; Secoli SR
    Int J Clin Pharm; 2011 Dec; 33(6):1002-9. PubMed ID: 21993569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of QT interval prolonging drug-drug interactions (QT-DDIs) in psychiatry wards of tertiary care hospitals in Pakistan: a multicenter cross-sectional study.
    Khan Q; Ismail M; Haider I; Khan F
    Int J Clin Pharm; 2017 Dec; 39(6):1256-1264. PubMed ID: 28895028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.